From: Green synchronous spectrofluorimetric analysis of remdesivir, the first approved antiviral, with levodropropizine as add-on therapy for covid-19: application in their pharmaceutical dosage form, and spiked human plasma
Parameters
Remdesivir
Levodropropizine
Proposed method
Reference method [19]
Reference method [39]
Number of measurements
5
Mean Recovery %
100.40
98.93
99.45
101.14
RSD %
1.331
0.740
1.447
0.930
Variance
1.785
0.535
2.070
0.885
Student’s t-testa (2.306)
2.158
——
2.201
F-valuea (6.388)
3.334
2.339